SURVEY: Understanding the Current Cancer Pharmacy Technician Landscape

The Pharmacy Technician Subcommittee and Research Subcommittee are conducting an education survey to find out the current level of education and training available to pharmacy technicians and the support they receive locally regarding pharmacy counselling on Systemic Anti-Cancer Therapies (SACT) and SACT prescription verification.

Over the past decade, pharmacy technicians’ roles have grown rapidly, and a better understanding of the local education and training infrastructure would help identify gaps or differences in training, as well as improving access to materials for healthcare providers, trainers, and technicians.

This survey also aims to gather information about your current qualifications, your role and responsibilities, and any further education you plan to pursue. The knowledge will contribute to the development of BOPA’s workforce pillar, the job and workforce planning.

Link to the survey – https://forms.office.com/e/qnvz00jQ5F

Results will be shared via BOPA, and your responses will be anonymous.

The term SACT refers to cytotoxic chemotherapy, immunotherapies, targeted therapies, and other pharmacotherapies for treating cancer.

It should take 20 -25 minutes to complete.

Sent on behalf

Pharmacy Technicians Subcommittee and Research Subcommittee

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article